1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6149AA5385975824500258921003988F5
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-benchmarking-real-world-uses-of-artificial-intelligence-in-medical-affairs-ai-for-personalized-engagement-key-lessons-learned?opendocument
18
19opendocument
2034.225.194.102
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Medical Affairs Excellence

Benchmarking Real-World Uses of Artificial Intelligence in Medical Affairs: AI for Personalized Engagement and Key Lessons Learned

ID: 5745


Features:

8 Info Graphics

13 Data Graphics

160+ Metrics

27 Narratives


Pages/Slides: 29


Published: 2022


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Benchmarking Real-World Uses of Artificial Intelligence in Medical Affairs: AI for Personalized Engagement and Key Lessons Learned”

STUDY OVERVIEW

The advent of machine learning and artificial intelligence (AI) technologies have transformed the way Medical Affairs engages with key stakeholders and implements critical strategies. Leveraging insights from AI technologies, Medical Affairs is now better equipped to forge stronger relationships with key stakeholders.

Best Practices, LLC conducted research to benchmark the use of artificial intelligence for personalized engagement. This study probes how leading companies are applying artificial intelligence within Medical Affairs to improve personalized engagement of stakeholders, facilitate omnichannel implementation, and gather insights. It also highlights the critical lessons learned for developing and deploying AI within a Medical Affairs organization.

KEY TOPICS

  • Current Use of Artificial Intelligence in Medical Affairs
  • Leveraging AI for Medical Omnichannel Engagement
  • Use of Artificial Intelligence for Personalized Engagement
  • Key Insights from AI Pilot Programs

KEY METRICS

  • What stage of AI implementation have Medical Affairs organizations reached?
  • Have any of the AI projects helped to support an omnichannel engagement program?
  • Have your Medical Affairs organizations experimented with any of the listed AI applications relating to personalized engagement?
  • How valuable are each of the AI applications leveraged for the purposes of personalized engagement?
  • Of the AI applications experimented with for personalized engagement, which provide the best insights?
  • What are the top three lessons learned for developing and deploying AI within a Medical Affairs organization?

SAMPLE KEY FINDINGS

  • Personalized Engagement: The top impact area involves using AI to improve content (which 86% of surveyed companies find highly valuable), followed by enhancement of MSL engagement (67%). Approximately half of companies find high value in HCP mapping, optimizing use of digital channels, and improving customer service.

METHODOLOGY

Best Practices, LLC engaged 29 Medical leaders from 22 pharma companies in this research through a benchmarking survey instrument.

Industries Profiled:
Biopharmaceutical; Medical Device; Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Health Care; Consulting; Communications; Clinical Research; Laboratories


Companies Profiled:
Apellis Pharmaceuticals; ASC Therapeutics; Baxter International; Bayer; Boehringer Ingelheim; Cormedix Inc.; Curis; Daiichi Sankyo; Eisai; EMD Serono; Indivior; Ipsen; Luzsana Biotechnology; Medexus Pharmaceuticals; MEDiSTRAVA; MedThink SciCom; Merck; Novartis; Sanofi; Straumann; Takeda Pharmaceuticals; Teva Pharmaceutical Industries Ltd

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.